Indirect Cost of Ischemic Heart Disease to EmployersByBruce Sherman, MD. Author Reply by Christine J. Guico-Pabia, MD, MBA,James F. Murray, PhD,Marc L. Berger, MD,Steven M. Teutsch, MD, MPHApril 1st 2001
Cost-Sharing for Prescriptions of Sildenafil and Finasteride: A Case Study in Veteran PatientsByEmily I. Yu, MPH,Peter A. Glassman, MBBS, MSc,Steven M. Asch, MD, MPH,Neil M. Paige, MD, MSHS,Leigh J. Passman, MD, PhD,Paul G. Shekelle, MD, PhDApril 1st 2001
Effects of Compensation Method on Physician BehaviorsByJames Tufano, MHA,Douglas A. Conrad, PhD,Anne Sales, PhD,Charles Maynard, PhD,Jay Noren, MD,Eric Kezirian, MD,Kenneth G. Schellhase, MApril 1st 2001
Healthy Pregnancy Program in a National Managed Care Organization: Evaluation of Satisfaction and Health Behavior OutcomesByCarol R. Drinkard, MPH, PhD,Deborah Shatin, PhD,Danni Luo, PhD,Mary Jane Heinen, PhD,Michael M. Hawkins, MD,Robert G. Harmon, MDApril 1st 2001
Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and CostByL. Clark Paramore, MSPH,Michael T. Halpern, MD, PhD,Pablo Lapuerta, MD,Judith S. Hurley, MS, RD,Floyd J. Frost, PhD,David G. Fairchild, MD, MPHApril 1st 2001
The Effect of Nonsteroidal anti-inflammatory Drugs on the Use of Gastroprotective Medication in People with ArthritisByKate L. Lapane, PhD,Joshua J. Spooner, PharmD,Dan Pettitt, DVM, MScApril 1st 2001
Achieving Control of Diabetic Risk Factors in Primary Care SettingsByAlain G. Bertoni, MD, MPHApril 1st 2001